CNTA
Centessa Pharmaceuticals
CNTA
CNTA
160 hedge funds and large institutions have $5.9B invested in Centessa Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 50 increasing their positions, 44 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
14% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 44
10% more funds holding
Funds holding: 145 → 160 (+15)
5.18% less ownership
Funds ownership: 106.95% → 101.77% (-5.2%)
Holders
160
Holding in Top 10
17
Calls
$31.9M
Puts
$23.2M
Top Buyers
| 1 | +$209M | |
| 2 | +$94M | |
| 3 | +$91.4M | |
| 4 |
Morgan Stanley
New York
|
+$80.8M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$73.8M |
Top Sellers
| 1 | -$122M | |
| 2 | -$98.2M | |
| 3 | -$79.9M | |
| 4 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$76.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$60.3M |
